Literature DB >> 12730531

Elements of fibromyalgia in an open population.

T Schochat1, H Raspe.   

Abstract

OBJECTIVE: To examine the nosological concept of fibromyalgia in the general population.
METHODS: A postal survey of rheumatic pain and non-specific bodily complaints was sent to all 3174 German female residents of Bad Säckingen, Germany, aged 35 to 74 yr. A stratified random sample of 653 subjects was further examined in a clinical survey.
RESULTS: On the population level the point prevalence of chronic widespread pain was 13.5%. In the clinical survey, tender point count was associated not only with the extent of rheumatic pain, but also independently with the extent of bodily complaints. Subjects with no history of rheumatic pain but with non-specific bodily complaints had as many positive tender points as subjects without bodily complaints but with a history of rheumatic pain. Subjects could be identified who met the tender point criterion of the ACR without a history of widespread pain. Multivariate analyses demonstrated that some symptoms carry a risk for positive tender points (low physical mobility, pain, bodily complaints) and some for chronic widespread pain (poor health status, catastrophizing, emotional reactions, low energy level, sleep disturbances) that are independent of each other and of age.
CONCLUSIONS: The results do not only question the relevance and specificity of a history of widespread pain in diagnosing fibromyalgia, but also the concept of fibromyalgia as a distinct rheumatological disorder. The results support the concept of fibromyalgia as part of a wider spectrum of dysfunctional syndromes.

Entities:  

Mesh:

Year:  2003        PMID: 12730531     DOI: 10.1093/rheumatology/keg199

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  15 in total

1.  Prevalence of chronic widespread pain and fibromyalgia syndrome: a Korean hospital-based study.

Authors:  Cheolhwan Kim; Hyejin Kim; Jongkwan Kim
Journal:  Rheumatol Int       Date:  2011-11-06       Impact factor: 2.631

Review 2.  Fibromyalgia: a rheumatologic diagnosis?

Authors:  Gerhard K M Endresen
Journal:  Rheumatol Int       Date:  2007-07-20       Impact factor: 2.631

3.  Work-related and psychological determinants of multisite musculoskeletal pain.

Authors:  Eleni Solidaki; Leda Chatzi; Panos Bitsios; Irini Markatzi; Estel Plana; Francesc Castro; Keith Palmer; David Coggon; Manolis Kogevinas
Journal:  Scand J Work Environ Health       Date:  2009-12-11       Impact factor: 5.024

4.  [Definition, classification and diagnosis of fibromyalgia syndrome].

Authors:  W Eich; W Häuser; E Friedel; A Klement; M Herrmann; F Petzke; M Offenbächer; M Schiltenwolf; C Sommer; T Tölle; P Henningsen
Journal:  Schmerz       Date:  2008-06       Impact factor: 1.107

5.  The relationship between tender point count and disease severity in patients with primary fibromyalgia.

Authors:  Ali Salli; Halim Yilmaz; Hatice Ugurlu
Journal:  Rheumatol Int       Date:  2010-07-30       Impact factor: 2.631

Review 6.  [Fibromyalgia--an update].

Authors:  W Brückle; H Zeidler
Journal:  Internist (Berl)       Date:  2005-11       Impact factor: 0.743

7.  Low-level laser therapy to treat fibromyalgia.

Authors:  J A Ruaro; A R Fréz; M B Ruaro; R A Nicolau
Journal:  Lasers Med Sci       Date:  2014-05-07       Impact factor: 3.161

8.  Prevalence of fibromyalgia in a low socioeconomic status population.

Authors:  Ana Assumpção; Alane B Cavalcante; Cristina E Capela; Juliana F Sauer; Suellen D Chalot; Carlos A B Pereira; Amélia P Marques
Journal:  BMC Musculoskelet Disord       Date:  2009-06-08       Impact factor: 2.362

9.  [Prevalence and predictors of pain in several body regions. Results of a representative German population survey].

Authors:  W Häuser; G Schmutzer; H Glaesmer; E Brähler
Journal:  Schmerz       Date:  2009-10       Impact factor: 1.107

10.  Tender point count and total myalgic score in fibromyalgia: changes over a 28-day period.

Authors:  J G McVeigh; M B Finch; D A Hurley; J R Basford; J Sim; G D Baxter
Journal:  Rheumatol Int       Date:  2007-07-20       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.